161 related articles for article (PubMed ID: 3142804)
1. Effect of an aldose reductase inhibitor, AL-1576, on the development of UV-B and X-ray cataract.
Schmitt C; Schmidt J; Wegener A; Hockwin O
Graefes Arch Clin Exp Ophthalmol; 1988; 226(5):455-60. PubMed ID: 3142804
[TBL] [Abstract][Full Text] [Related]
2. Effects of two new aldose reductase inhibitors, AL-1567 and AL-1576, in diabetic rats.
Griffin BW; McNatt LG; Chandler ML; York BM
Metabolism; 1987 May; 36(5):486-90. PubMed ID: 3106757
[TBL] [Abstract][Full Text] [Related]
3. AL-1576, an aldose reductase inhibitor (ARI), did not prevent the decrease of norepinephrine turnover in diabetic rats.
Yen TT; Fuller RW; Broderick CL; Hemrick-Luecke SK; Perry KW
Res Commun Chem Pathol Pharmacol; 1988 Aug; 61(2):257-60. PubMed ID: 3141993
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of aldehyde reductase by aldose reductase inhibitors.
Sato S; Kador PF
Biochem Pharmacol; 1990 Sep; 40(5):1033-42. PubMed ID: 2117925
[TBL] [Abstract][Full Text] [Related]
5. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
Kador PF; Lee JW; Fujisawa S; Blessing K; Lou MF
J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425
[TBL] [Abstract][Full Text] [Related]
6. [Aldose reductase inhibitor--a new way for preventing diabetic lens changes?].
Ohrloff C; Hockwin O; Korte I; Wegener A
Klin Monbl Augenheilkd; 1986 Nov; 189(5):361-2. PubMed ID: 3100860
[TBL] [Abstract][Full Text] [Related]
7. Raman spectroscopic study of the effect of aldose reductase inhibitor on experimental diabetic cataract.
Nozawa H; Yaginuma T; Mizuno A
Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):194-201. PubMed ID: 3133929
[No Abstract] [Full Text] [Related]
8. [The role of lens epithelium in cataract formation in diabetic rats].
Fan W; Yan M; Hu Y; Li G
Hua Xi Yi Ke Da Xue Xue Bao; 1998 Jun; 29(2):185-8. PubMed ID: 10684012
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of aldose reductases from rat and bovine lenses by hydantoin derivatives.
Inagaki K; Miwa I; Yashiro T; Okuda J
Chem Pharm Bull (Tokyo); 1982 Sep; 30(9):3244-54. PubMed ID: 6816474
[No Abstract] [Full Text] [Related]
10. The role of aldose reductase in sugar cataract formation: aldose reductase plays a key role in lens epithelial cell death (apoptosis).
Murata M; Ohta N; Sakurai S; Alam S; Tsai J; Kador PF; Sato S
Chem Biol Interact; 2001 Jan; 130-132(1-3):617-25. PubMed ID: 11306080
[TBL] [Abstract][Full Text] [Related]
11. Dynamic phosphorus-31 NMR study of sugar cataract and its prevention in rat lenses with aldose reductase inhibitors.
Thomas DM; Mahendroo PP; Lou MF
Exp Eye Res; 1988 Jan; 46(1):37-47. PubMed ID: 3125056
[TBL] [Abstract][Full Text] [Related]
12. Prefeeding of aldose reductase inhibitor and galactose cataractogenesis.
Unakar NJ; Tsui JY; Johnson MJ
Curr Eye Res; 1989 Oct; 8(10):997-1010. PubMed ID: 2558845
[TBL] [Abstract][Full Text] [Related]
13. [Prevention of rat galactose cataract with topical aldose reductase inhibitor, E-1008].
Tasaka H; Akagi Y; Yoshikawa T; Ikebe H; Takahashi Y; Chamoto K; Miyamoto Y; Terubayashi H
Nippon Ganka Gakkai Zasshi; 1987 Feb; 91(2):246-53. PubMed ID: 3111200
[No Abstract] [Full Text] [Related]
14. Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor.
Beyer-Mears A; Cruz E
Diabetes; 1985 Jan; 34(1):15-21. PubMed ID: 3917257
[TBL] [Abstract][Full Text] [Related]
15. [Movement of regenerated lens epithelial cells in 50% galactose cataract and an aldose reductase inhibitor].
Terubayashi H; Tsuji T; Matumoto Y; Ikebe H; Akagi Y
Nippon Ganka Gakkai Zasshi; 1989 Nov; 93(11):1044-53. PubMed ID: 2513712
[TBL] [Abstract][Full Text] [Related]
16. Cataract prevention in diabetic Octodon degus with Pfizer's sorbinil.
Datiles MB; Fukui H
Curr Eye Res; 1989 Mar; 8(3):233-7. PubMed ID: 2523284
[TBL] [Abstract][Full Text] [Related]
17. Direct stimulation of Na+-K+-ATPase and its glucosylated derivative by aldose reductase inhibitor.
Garner MH; Spector A
Diabetes; 1987 Jun; 36(6):716-20. PubMed ID: 3032716
[TBL] [Abstract][Full Text] [Related]
18. Effects of an aldose reductase inhibitor, 1-[(p-bromophenyl)-sulfonyl]hydantoin, on cataract formation and tissue polyol levels in galactosemic rats.
Okuda J; Yashima K; Inagaki K; Miwa I
Chem Pharm Bull (Tokyo); 1985 Jul; 33(7):2990-5. PubMed ID: 3936627
[No Abstract] [Full Text] [Related]
19. Aldose reductase inhibitors and prevention of galactose cataracts in rats.
Unakar N; Tsui J; Johnson M
Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1623-32. PubMed ID: 2545646
[TBL] [Abstract][Full Text] [Related]
20. Determination of AL01576 concentration in rat lenses and plasma by bioassay for aldose reductase activity measurements.
Hockwin O; Müller P; Krolczyk J; McCue BA; Mayer PR
Ophthalmic Res; 1989; 21(4):285-91. PubMed ID: 2511536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
